Risk-based monitoring (RBM): A shift in paradigm from the traditional experimental design - podcast

Mark Penniston and Alison Taber

Thought Leaders: Mark Penniston, Senior Vice President and General Manager, Clinical Analytics, Theorem Clinical Research and Alison Taber, Vice President of Global Data Management, Theorem Clinical Research

In this episode, Mr. Penniston and Ms. Taber talk about risk-based monitoring what it is, why it's important, what are the components, what skill sets or tools are necessary, and the challenges and opportunities related to risk-based monitoring.

Download Full Podcast

See All PharmaVOICE Podcasts

See All PharmaVOICE White Papers

Risk-Based Monitoring for Late-Phase Research

Risk-based Monitoring White Paper

A number of factors are leading to the paradigm shift in the way that clinical research is conducted. The increasing cost of research and the adoption of EDC technologies that provide real-time access to data have forced the industry to look at optimized methods of conducting clinical studies. In addition, several studies have shown that 100% SDV may not result in higher data quality. All of these factors have led to increased interest in RBM strategies.

Download white paper
Risk-Based Monitoring for Late-Phase Research

Download Related Podcast
Risk-Based Monitoring for Late Phase: Implementation Strategies

Download Podcast Transcript

See All PharmaVOICE White Papers

See All PharmaVOICE Podcasts

Risk-Based Monitoring for Late Phase: Implementation Strategies

Maria Harrison, Vice President, Late Phase Services, PRA

In this podcast, Maria Harrison discusses the past, present, and future of Risk-based Monitoring. She also covers challenges and solutions, as well as a real-life example of RBM in a clinical study.

Download Podcast
Risk-Based Monitoring for Late Phase: Implementation Strategies

Download Podcast Transcript

Download related white paper
Risk-Based Monitoring for Late-Phase Research

See All PharmaVOICE Podcasts

See All PharmaVOICE White Papers